Ruiz A M, Kwak J Y, Kwak F M, Beer A E
Department of Microbiology and Immunology, Finch University of Health Sciences, Chicago Medical School, IL 60064, USA.
Am J Reprod Immunol. 1996 Apr;35(4):408-14. doi: 10.1111/j.1600-0897.1996.tb00502.x.
The objective of this paper is to determine whether age has any impact on conception rate, pregnancy outcome, or autoimmune status in women with recurrent spontaneous abortions (RSA) and infertility of immune etiology. One hundred twenty-four women with 3 or more RSA and 36 women with unexplained infertility were prospectively studied. Maternal antipaternal lymphocyte antibodies and autoantibodies to phospholipids and nuclear antigens were tested. All achieved an adequate alloimmune recognition after lymphocyte immunization and followed for 1 year with optimal preconception autoimmune treatment. Conception rate and pregnancy outcome were prospectively studied. 1) 10.1% of women with RSA and 30.6% of women with infertility failed to achieve a pregnancy after 1 year of trial (P = 0.0084); 2) in women with RSA, the number of previous fetal death after 28 weeks of gestation was significantly higher in women who failed to achieve a pregnancy within 1 year when compared to women who became pregnant (P = 0.0296). Conception rate was not different with advancing age; 3) women with infertility demonstrated significantly higher incidence of anti-phosphatidylethanolamine antibody when compared to women with RSA (P = 0.052); 4) in women with infertility, those who failed to achieve a pregnancy were significantly older (P = 0.0012) and demonstrated a higher incidence of autoantibodies to phosphatidic acid than women with infertility who became pregnant (P = 0.0339); 5) the subsequent spontaneous abortion rate while on optimal immune therapy was the same in the women with RSA (39.3%) and women with infertility (32%). Spontaneous abortion rate of women with RSA or infertility was not different among four age groups; 6) the presence of anticardiolipin antibody (P = 0.0055) and higher gravidity (P = 0.0354) correlated significantly with pregnancy failure in women with a history of infertility. The prevalence of auto-antibodies to phospholipids and nuclear components was not different among four age groups in women with RSA or infertility. Age does not affect pregnancy outcome or conception rate in women with RSA. In women with infertility of immune etiology, conception rate was significantly reduced over age 40 although pregnancy outcome was no different with advanced age.
本文的目的是确定年龄对反复自然流产(RSA)且有免疫病因不孕症女性的受孕率、妊娠结局或自身免疫状态是否有影响。对124例有3次或更多次RSA的女性和36例不明原因不孕症女性进行了前瞻性研究。检测了母体抗父系淋巴细胞抗体以及针对磷脂和核抗原的自身抗体。所有患者在淋巴细胞免疫后均实现了充分的同种免疫识别,并在孕前进行最佳自身免疫治疗的情况下随访1年。对受孕率和妊娠结局进行了前瞻性研究。1)RSA女性中有10.1%、不孕症女性中有30.6%在试验1年后未受孕(P = 0.0084);2)在RSA女性中,与成功受孕的女性相比,1年内未受孕的女性妊娠28周后既往胎儿死亡数显著更高(P = 0.0296)。受孕率不会随年龄增长而有差异;3)与RSA女性相比,不孕症女性中抗磷脂酰乙醇胺抗体的发生率显著更高(P = 0.052);4)在不孕症女性中,未受孕者年龄显著更大(P = 0.0012),且与成功受孕的不孕症女性相比,其抗磷脂酸自身抗体的发生率更高(P = 0.0339);5)在进行最佳免疫治疗时,RSA女性(39.3%)和不孕症女性(32%)的后续自然流产率相同。RSA或不孕症女性的自然流产率在四个年龄组中无差异;6)有不孕症病史的女性中,抗心磷脂抗体的存在(P = 0.0055)和较高的妊娠次数(P = 0.0354)与妊娠失败显著相关。RSA或不孕症女性中,四个年龄组针对磷脂和核成分的自身抗体患病率无差异。年龄不影响RSA女性的妊娠结局或受孕率。在有免疫病因不孕症的女性中,40岁以上受孕率显著降低,不过妊娠结局与高龄无关。